Literature DB >> 16212464

Endovascular treatment of an internal iliac artery aneurysm using a nitinol vascular occlusion plug.

Nicolas Diehm1, Ralph Kickuth, Antonio Silvestro, Sebastian T Schindera, Bernhard Meier, Iris Baumgartner, Jürg Schmidli, Jürgen Triller, Felix Mahler, Dai-Do Do.   

Abstract

PURPOSE: To report endovascular occlusion of an internal iliac artery (IIA) aneurysm with an Amplatz nitinol vascular occlusion plug. CASE REPORT: A 71-year-old asymptomatic man who had previously undergone open aortic aneurysm repair presented for annual follow-up. A bifurcated Dacron graft had been inserted 12 years ago from the infrarenal aorta to the left common femoral artery and the right common iliac artery. The left common iliac artery was ligated proximally, and the left external iliac artery (EIA) provided retrograde flow into the IIA. Magnetic resonance imaging (MRI) revealed a 7.4-cm aneurysm of the left IIA. After transfemoral calibrated catheter angiography was performed, the proximal EIA was occluded with an Amplatz nitinol vascular occlusion plug. In addition, microcoils were placed distal to the vascular plug to achieve complete thrombosis of the vessel. One day after treatment, the patient was discharged free of symptoms after MRI had shown complete obliteration of the IIA aneurysm. At 6 months, the patient was free from symptoms, and angiography confirmed exclusion of the IIA aneurysm.
CONCLUSIONS: This case illustrates the technical feasibility and successful short-term follow-up of a novel embolization approach to IIA aneurysms in patients with an aortofemoral graft.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212464     DOI: 10.1583/05-1505MR.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  1 in total

1.  The Amplatzer vascular plug for large vessel occlusion in the endovascular management of aneurysms.

Authors:  Lakshmi A Ratnam; Richard M Walkden; Graham J Munneke; Robert A Morgan; Anna-Maria Belli
Journal:  Eur Radiol       Date:  2008-04-17       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.